INVO Fertility has the right to sell Alumni Capital up to $15 million of common stock, with a possible increase to $50 million by mutual agreement. The company has already sold 2,094,395 shares for approximately $3,591,000, giving investors a defined view of its available Equity funding and completed issuance.

Key Highlights

  • INVO Fertility has access to a common-stock purchase arrangement allowing sales of up to $15 million to Alumni Capital.
  • The commitment could increase to $50 million through mutual written agreement.
  • INVO Fertility posted its investor presentation on August 28, 2026, after selling 2,094,395 shares under the arrangement.

Arrangement Provides Access to Common-Stock Sales

INVO Fertility, Inc. (NASDAQ: IVF) has access to a common-stock purchase arrangement allowing sales of up to $15 million to Alumni Capital. The arrangement is presented as an available mechanism for selling common shares, with the article identifying the $15 million figure as the aggregate commitment.

The stated value of the securities is $0.0001 per share. That stated value is included in the description of the securities covered by the arrangement and should be distinguished from the separate $15 million aggregate commitment identified in the article.

Aggregate Commitment and Potential Increase

The $15 million amount represents the aggregate commitment associated with the arrangement.

Any increase would require mutual written agreement between the parties. Even if such an agreement were reached, the increased amount could not exceed $50 million, establishing the maximum described for a possible expansion.

Shares Sold Since Registration Effectiveness

Since the registration statement covering the shares became effective, INVO Fertility has sold 2,094,395 common shares under the arrangement. The reported share figure therefore relates specifically to sales made after the registration statement became effective.

The article presents the share total alongside the arrangement’s commitment information. It does not identify another share total, another purchaser, or another common-stock purchase arrangement in connection with the reported sales.

Relationship Between Shares and Commitment

The reported 2,094,395 common shares are a record of sales under the arrangement, while the $15 million figure describes the aggregate commitment available through that arrangement. These are different disclosures addressing shares sold and the commitment amount.

The stated value of $0.0001 per share is a separate detail concerning the securities. The article supplies all three figures together: the stated value, the aggregate commitment, and the number of common shares sold since effectiveness.

September Investor Conference Presentation

INVO Fertility posted the September investor conference presentation in the Investors section of its website on August 28, 2026. The article identifies the posting date and the website location, linking the presentation to the company’s investor materials.

The presentation includes forward-looking statements. Those statements are subject to the cautionary language contained in the presentation, so the cautionary language forms part of the document’s stated context.

Executive Signature and Document Date

Steven Shum, chief executive officer, signed the document for INVO Fertility on August 28, 2026. The signature date matches the date given for posting the presentation to the Investors section of the company’s website.

The article therefore connects the arrangement disclosures with a dated investor presentation and an identified executive signatory. It does not provide additional presentation content beyond the forward-looking-statement reference and the cautionary-language disclosure.

Peers Moving on This News